Market Research Logo

Indonesia Pharmaceuticals and Healthcare Report Q2 2016

Indonesia Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The challenges facing domestic pharmaceutical firms in Indonesia will continue. While effortsto alleviate the country's reliance on pharmaceutical raw material imports are underway, these are unlikelyto have a substantial impact until 2017. Moreover, the ability of Indonesia's universal healthcare programmeto facilitate sales will be constrained by the country's medical services infrastructure, and low commodityprices will weigh on the economy and household purchasing power.

Headline Expenditure Projections

Pharmaceuticals: IDR77,643bn (USD5.7bn) in 2015 to IDR85,550bn(USD5.9bn) in 2016; +10.2%growth in local currency terms and 3.2% in US dollar terms.

Healthcare: IDR347,253bn (USD25bn) in 2015 to IDR387,513bn (USD27bn) in 2016; +11.6% growthin local currency terms and 4.6% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Indonesia 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Indonesia 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Indonesia 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Indonesia 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Indonesia 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Indonesia 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Indonesia 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Indonesia 2014-2020)
Industry Risk/Reward Index
Asia Pacific Risk/Reward Index
Indonesia Risk/Reward Index
Rewards
Risks
Regulatory Review
Pharmaceutical Advertising
Regional Harmonisation
Intellectual Property Issues
Halal Medicine Regulations
Labelling Requirements
Compulsory Licensing
Counterfeit Drugs
Generic Drug Legislation
Pricing Regime
Reimbursement Regime
Industry Trends And Developments
Market Overview
Public Health Developments
Table: UN Millennium Development Goals For Indonesia
Healthcare System
Health Insurance
Table: Healthcare Resources (Indonesia 2010-2015)
Table: Healthcare Personnel (Indonesia 2010-2015)
Table: Healthcare Activity (Indonesia 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Table: Estimated Number Of New Cases Of Cancer In Indonesia
Competitive Landscape
Research-Based Industry
Table: Selected List Of Pharmaceutical Business Areas With Restricted Conditions
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Wholesale
Pharmaceutical Retail
Company Profile
Bayer
Darya-Varia Group
GlaxoSmithKline
Indopharma
Kimia Farma
Merck & Co
Merck Group
Novartis
Pfizer
PT Biofarma
PT Kalbe Farma
Sanofi
Soho Group
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Indonesia 1990-2025)
Table: Key Population Ratios (Indonesia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Indonesia 1990-2025)
Table: Population By Age Group (Indonesia 1990-2025)
Table: Population By Age Group % (Indonesia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report